Back to Search
DR. MARK D TABER M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1336100650IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
R9F84(MO)036062673(IL)
Interventional Cardiology Physician
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
R9F84(MO)
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1978
Research & Publications (17)
Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
PMID 19560923·Bioorg Med Chem Lett·2009
7-preclinical
Civilian helicopter accidents into water: analysis of 46 cases, 1979-2006.
PMID 18856182·Aviat Space Environ Med·2008
8-other
An orally active corticotropin releasing factor 1 receptor antagonist from 8-aryl-1,3a,7,8-tetraaza-cyclopenta[a]indenes.
PMID 17258456·Bioorg Med Chem Lett·2007
7-preclinical
IMPACTS project: preparing therapists to provide best practice early intervention services.
PMID 17613457·Phys Occup Ther Pediatr·2007
8-other
Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
PMID 17391962·Bioorg Med Chem Lett·2007
7-preclinical
Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130.
PMID 15740795·Pharmacol Biochem Behav·2005
4-observational
Optimization of CRF1R binding affinity of 2-(2,4,6-trichlorophenyl)-4-trifluoromethyl-5-aminomethylthiazoles through rapid and selective parallel synthesis.
PMID 15603967·Bioorg Med Chem Lett·2005
8-other
Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists.
PMID 15982881·Bioorg Med Chem Lett·2005
8-other
Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists.
PMID 15990298·Bioorg Med Chem Lett·2005
7-preclinical
Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.
PMID 16162005·J Med Chem·2005
7-preclinical
Synthesis and SAR exploration of dinapsoline analogues.
PMID 14759732·Bioorg Med Chem·2004
7-preclinical
2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy.
PMID 14592493·Bioorg Med Chem Lett·2003
7-preclinical
(+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist.
PMID 12166939·J Med Chem·2002
7-preclinical
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
PMID 11160615·J Pharmacol Exp Ther·2001
7-preclinical
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.
PMID 11283675·Nat Med·2001
7-preclinical
Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
PMID 10941137·Synapse·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 4445 W IRVING PARK RD STE 200
CHICAGO, IL 60641 - Phone
- (312) 664-3278
Locations (4)
Quick Facts
- NPI
- 1336100650
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 4
- Years in Practice
- 48
- Publications
- 17
Are you this provider?
Claim Your Profile